GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.1148
+0.0096 (9.13%)
Aug 21, 2026, 5:35 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €26.92 million as of August 21, 2026. Its market cap has increased by 8.46% in one year.
Market Cap
26.92M
Enterprise Value
37.37M
Revenue
652.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.11
ChartMarket Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 26.92M, a decrease of -89.32%. That is a compound annual growth rate of -19.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 26.92M | 16.93% |
| Dec 31, 2025 | 23.02M | -30.35% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| THX Pharma Société Anonyme | 59.05M |
| MaaT Pharma | 58.79M |
| Fermentalg | 44.57M |
| Nicox | 33.75M |
| Advicenne | 24.44M |
| genOway Société anonyme | 22.59M |
| Aelis Farma | 14.66M |
| Aton | 12.75M |